ACE Inhibition Is Renoprotective among Obese Patients with Proteinuria

Obesity may increase the risk for progression of CKD, but the effect of established renoprotective treatments in overweight and obese patients with CKD is unknown. In this post hoc analysis of the Ramipril Efficacy In Nephropathy (REIN) trial, we evaluated whether being overweight or obese influence...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Mallamaci, Francesca, Ruggenenti, Piero, Perna, Annalisa, Leonardis, Daniela, Tripepi, Rocco, Tripepi, Giovanni, Remuzzi, Giuseppe, Zoccali, Carmine
Format: Artigo
Jezik:Inglês
Izdano: American Society of Nephrology 2011
Teme:
Clinical Epidemiology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3103731/
https://ncbi.nlm.nih.gov/pubmed/21527660
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2010090969
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki